| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b29ba1a7f2e238a79002c95123eab8a3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3d35964cd8d0125fff44d1a0f0d58b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_537765862e782a3ac532a6a061b8560f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25c235a30090665e93e217a219e9e28f |
| publicationDate |
2014-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014007778-A1 |
| titleOfInvention |
COMBINED IMMEDIATE RELEASE FORMULATIONS OF NSAIDs |
| abstract |
The present invention is related to a pharmaceutical formulation which comprises NSAID having antiinflamatory, analgesic and antipyretic effect together with an H2 receptor antagonist used for preventing and minimizing the gastrointestinal side effects of NSAID. According to another aspect, the present invention relates to the fact, that the pharmaceutical formulation comprising NSAID as the first drug substance and H2 receptor antagonist as second active substance is a novel solid oral multilayer tablet |
| priorityDate |
2012-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |